Cite
High remission rates and transition to allogeneic transplant in older patients with newly diagnosed FLT-3 mutated acute myelogenous leukemia with midostaurin plus intensive chemotherapy.
MLA
Tinajero, Jose, et al. “High Remission Rates and Transition to Allogeneic Transplant in Older Patients with Newly Diagnosed FLT-3 Mutated Acute Myelogenous Leukemia with Midostaurin plus Intensive Chemotherapy.” Leukemia & Lymphoma, vol. 65, no. 7, July 2024, pp. 1020–23. EBSCOhost, https://doi.org/10.1080/10428194.2024.2332506.
APA
Tinajero, J., Ngo, D., Zhang, J., Tsai, N.-C., Aribi, A., Aldoss, I., Agrawal, V., Arslan, S., Amanam, I., Pourhassan, H., Sandhu, K., Al-Malki, M., Pullarkat, V., Becker, P., Nakamura, R., Stein, A., Marcucci, G., Artz, A., Koller, P., & Salhotra, A. (2024). High remission rates and transition to allogeneic transplant in older patients with newly diagnosed FLT-3 mutated acute myelogenous leukemia with midostaurin plus intensive chemotherapy. Leukemia & Lymphoma, 65(7), 1020–1023. https://doi.org/10.1080/10428194.2024.2332506
Chicago
Tinajero, Jose, Dat Ngo, Jianying Zhang, Ni-Chun Tsai, Ahmed Aribi, Ibrahim Aldoss, Vaibhav Agrawal, et al. 2024. “High Remission Rates and Transition to Allogeneic Transplant in Older Patients with Newly Diagnosed FLT-3 Mutated Acute Myelogenous Leukemia with Midostaurin plus Intensive Chemotherapy.” Leukemia & Lymphoma 65 (7): 1020–23. doi:10.1080/10428194.2024.2332506.